BMY - Bristol-Myers Squibb Co.

Day 1m 10m 60m PreMarket Market AfterHours Gap
43.91 -0.3 (-0.68%) --- --- --- -0.21 (-0.48%) -0.16 (-0.37%) -0.01 (-0.02%) -0.01 (-0.02%)

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
0.64
Diluted EPS:
0.64
Basic P/E:
68.1406
Diluted P/E:
68.1406
RSI(14) 1m:
0.0
VWAP:
43.61
RVol:
0.5296

Events

Period Kind Movement Occurred At

Related News